share_log

Adaptimmune Therapeutics | 3: Initial statement of beneficial ownership of securities-10% Owner EcoR1 Capital, LLC

SEC announcement ·  Mar 26 12:04
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more